期刊文献+

鸡β-肌动蛋白第一内含子对EIAV载体质粒外源蛋白表达能力的影响

Influence of the Chicken β-actin Intron 1 on the EGFP Expression of Gene Transfer Vector Derived from Equine Infectious Anemia Virus
下载PDF
导出
摘要 以马传染性贫血病毒(equine infectious anemia virus,EIAV)基因转移载体pcPPTW PRE为基础,用含不同长度片段的鸡β-肌动蛋白启动子替换原有的人巨细胞病毒立即早期启动子(CMVIEp)启动外源基因的表达,分别构建了2个基因转移载体,含部分第一内含子的pWCAGP0.8和含全长内含子的pWCAGP1.6。连同已构建的不含内含子的质粒pcPPTWCAG,采用磷酸钙法分别转染HEK293细胞和DF-1细胞,利用荧光显微镜观察报告基因eGFP蛋白的表达。并利用流式细胞仪定量。统计学分析结果表明,在HEK293细胞中,pcPPTWCAG、pWCAGP0.8和pWCAGP1.6表达阳性率分别为47.9%、46.1%和23.8%,转染后48h,收获细胞,利用流式细胞仪比较转染细胞中EGFP表达阳性细胞的百分率。结果表明,在HEK293细胞中,pcPPTWCAG、pWCAGP0.8和pWCAGP1.6的阳性细胞分别占计数细胞的47.9%、46.1%和23.8%;在DF-1细胞中,依次分别为12.4%、9.5%和4.2%,pcPPTWCAG与pWCAGP1.6差异显著。表明不含内含子的EIAV载体质粒表达EGFP的能力高于含部分和全长内含子的载体。 Based on the EIAV vector pcPPTWPRE, the plasmids pWCAGP0.8 containing part of the chicken β-actin intron 1 and pWCAGP1.6 containing the full intron were constructed by restriction enzyme digestion. Then the EIAV gene transfer vectors pWCAGP0. 8, pWCAGP1. 6 and pcPPTWCAG which were previously constructed without the chicken β-actin intron 1 were transfected into HEK293 cells and DF-1 cells using Calcium Phosphate Transfection Kit, respectively. The cells were investigated under fluorescence microscope at 12h,24h,36h and 48h after transfection. Flow-cytometric analysis was carried out at 48h. Results showed that the pcPPTWCAG had the equal EGFP expression level with pWCAGP0.8 ,while both of them could express EGFP much more efficiently than pWCAGP1.6 in HEK293 cells. In DF-1 cells, the pcPPTWCAG could express the EGFP a little more efficiently than pWCAGP0.8, while both of them could express EGFP much more efficiently than pWCAGP1.6. Results indicated that the chicken β-actin intron 1 could decrease, rather than increase the EGFP expression of EIAV vectors in both HEK293 cells and DF-1 cells.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第11期77-81,共5页 China Biotechnology
关键词 马传染性贫血病毒 基因转移载体 鸡β-肌动蛋白第一内含子 增强绿色荧光蛋白 Equine infectious anemia virus (EIAV) Gene transfer vector Chicken β-actin intron 1 EGFP
  • 相关文献

参考文献16

  • 1王晓斌,刘国仰.有关内含子功能研究的新进展[J].中华医学遗传学杂志,2000,17(3):211-212. 被引量:33
  • 2宁云山,李妍,周明乾,周宏伟,王小宁,曾溢滔.TPO内含子Ⅴ可显著增强人血小板生成素基因在乳腺细胞中的表达[J].中国生物化学与分子生物学报,2007,23(7):537-541. 被引量:4
  • 3Azzouz M, Mazarakis N. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases. Current Gene Therapy. 2004,4 ( 3 ) : 277 - 286.
  • 4Whitelaw C B, Radcliffe P A, Ritchie W A, et al. Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector. FEBS Lett,2004,571:233 -236.
  • 5Lu S, Cullen B R. Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells. RNA, 2003,9 : 618 - 630.
  • 6Rose A B, Beliakoff J A. Intron-mediated enhancement of gene expression intron sequences and splicing . Plant Physiol,2000, 122:535-542.
  • 7王泽平,张景迎,庞呈义.内含子增强脂质体介导的转基因表达[J].泰山医学院学报,2000,21(2):92-94. 被引量:4
  • 8Bu Z G,Ling Y,Marianne J S,et al. Enhancement of immune response to an HIV env DNA vaccine by a C-terminal segment of Listeriolysin O. AIDS Research and Human Retroviruses, 2003,19 : 409 - 420.
  • 9Bu Z G,Ling Y,Ziegler H K,et al. Enhanced cellular immuneresponse against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins. Virology ,2003,309:272 - 281.
  • 10姜永萍,张洪波,步志高,李呈军,赵有淑,王秀荣,于康震,陈化兰.表达载体pCAGGS显著增强禽流感DNA疫苗的免疫保护效果[J].中国农业科学,2006,39(4):825-830. 被引量:29

二级参考文献30

  • 1姜永萍,于康震,邓国华,田国斌,乔传玲,陈化兰.表达H5亚型禽流感病毒HA基因的DNA疫苗免疫保护效力研究[J].中国农业科学,2004,37(7):1071-1075. 被引量:11
  • 2Kan J L,Genes Development,1999年,13期,462页
  • 3Kim C H,J Bio Chem,1999年,274卷,6507页
  • 4Kilpatrick M W,Mol Med Today,1998年,4期,376页
  • 5Pan T,Curr Opin Chem Biol,1997年,1卷,1期,17页
  • 6Chen Z,Sahashi Y,Matsuo K,Asanuma H,Takahashi H,Iwasaki T,Suzuki Y,Aizawa C,Kurata T,Tamura S.Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza.Vaccine,1998,16:1544-1549.
  • 7Chen H L,Yu K Z,Jiang Y P,Tang X Y.DNA immunization elicits high HI antibody and protects chicken from AIV challenge.Options for the control of influenza IV.Immuntional Congress Series 1219,2001:917-921.
  • 8Tran T H,Nguyen T L,Nguyen T D,Luong T S,Pham P M,Nguyen V C,Pham T S,Vo C D,Le T Q,Ngo T T,Dao B K,Le P P,Nguyen T T,Hoang T L,Cao V T,Le T G,Nguyen D T,Le H N,Nguyen K T,Le H S,Le V T,Christiane D,Tran T T,Menno de J,Schultsz C,Cheng P,Lim W,Horby P,Farrar J.World Health Organization International Avian Influenza Investigative Team.Avian influenza A (H5N1) in 10 patients in Vietnam.The New England Journal of Medicine,2004,350:1179-1188.
  • 9Mase M,Tsukamoto K,Imada T,Imai K,Tanimura N,Nakamura K,Yamamoto Y,Hitomi T,Kira T,Nakai T,Kiso M,Horimoto T,Kawaoka Y,Yamaguchi S.Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan.Virology,2005,332:167-176.
  • 10Peiris J S,Yu W C,Leung C W,Cheung C Y,Ng W F,Nicholls J M,Ng T K,Chan K H,Lai S T,Lim W L,Yuen K Y,Guan Y.Re-emergence of fatal human influenza A subtype H5N1 disease.Lancet,2004,363:617-619.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部